Proactiveinvestors recommends
Additional Information
Market: OTCBB
Sector: Pharmaceuticals & Biotechnology
EPIC: BONU
Latest Price: $0.10  (0,00%)
52-week High: $0.00
52-week Low: $0.00
Market Cap: $10.30M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
BioNeutral Group
www.bioneutralgroup.com

Headquartered at the New Jersey Institute of Technology in Newark, New Jersey is a Life Science specialty chemical company with a focus on commercializing a game changing environmentally safe combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous microorganisms including bacteria, viruses, mold and difficult to eliminate health threatening spores. Using this approach BioNeutral has developed a cutting edge disruptive family of products initially focused in the health care arena and in National Defense . These ground breaking products have been approved for use in Germany, US/EPA approval is expected in mid 2010.

Full BioNeutral Group profile here
Is BONU a Buy, Sell or Hold?Get your FREE analysis of BONU
Pdf

BioNeutral's chief scientist invited to meet Minister of Health and Agriculture of Goa, India

5th Oct 2010, 7:18 am The group is invited for talks to explore how its specialty antimicrobial disinfectants, cleaners and toxic gas neutralizers could improve the health and environment of Goa

Specialty chemical company BioNeutral Group (OTCBB:BONU) said Monday that its chief scientist, Dr. Andrew Kielbania, has been invited to meet the Minister of Health and Agriculture of Goa, India, as well as representatives of the Ministry of Health.

The Minister wants to explore how BioNeutral's specialty antimicrobial disinfectants, cleaners and toxic gas neutralizers could improve the health and environment of Goa, the company said.

Goa, located in southwest India on the Arabian Sea, is one of India's richest states, with the highest GDP per capita in India. With its mild climate, destination resorts and cosmopolitan cities, international tourism is an important industry, among others including agricultural products, chemicals, pharmaceuticals and hospitality.

"We believe that both our innovative Ygiene antimicrobial products and our Ogiene cleaners and toxic gas eliminators will be well received by the Ministry. We know that our products can deliver significant beneficial attributes to improve the healthcare of Goa and we should have very productive discussions," said Kielbania.

BioNeutral has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The company's products, Ygiene and Ogiene, kill germs and clean surfaces with high speed and power. Its technology has been proven effective in surface, water and airborne applications.

The company's antimicrobial line of products under the Ygiene brand have been submitted to the EPA for approval for sale in the United States, and have already been approved for sale in Germany, the UK, France and Sweden. Ogiene is currently commercially available in the United States.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.